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Background: Although mild to moderate mental health problems are common and often debilitating, treatment
options in primary care settings in New Zealand are often severely limited for patients with these conditions.
Previously, we developed an ultra-brief intervention (UBI) to address mild to moderate psychological concerns,
designed to be delivered by primary care clinicians. Recent feasibility testing, including an adaptation for Māori
individuals (the indigenous people of New Zealand), showed that the brief intervention was feasible and acceptable to
both clinicians and their patients. This protocol describes a large pragmatic randomized controlled trial of our UBI
in primary care settings across the greater Wellington region, compared with practice as usual.
Methods/Design: We are using a two-arm cluster randomized controlled trial, with primary care practices randomized
to exclusively deliver either the UBI or practice as usual to all their recruited participants. The structured, guided
self-help UBI is delivered in three brief general practitioner (GP) appointments over a five week period. Participants are
invited into the study based on partner primary health organization access criteria (youth, people with low income, or
people with Māori or Pacific Island heritage). Improvements in mental health from baseline to post-treatment will be
compared between the intervention and control groups using a mixed-models application of analysis of covariance.
Data analysis will be on an intention-to-treat basis, to increase the real-world relevance of UBI and to meet the study's
objective of releasing UBI to primary care clinicians nationwide.
Discussion: The UBI is a first-line intervention tool for GPs that models the stepped care approach advocated in New
Zealand, against a background of limited access to treatments for often-overlooked patient groups. It is proposed to be
accessible to clinicians and patients alike, with the potential to be relevant to primary care clinicians across New Zealand.
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The recently released Global Burden of Disease Study
(GBD 2010) highlighted mental health and substance
use as leading causes of disability and a worldwide
health priority [1]. Mental and substance use disorders
now represent 7.4 % of disability-adjusted life years [2]
and 6 of the 20 leading causes of disability are attributable
to mental health issues [3]. In line with international find-
ings, just under 40 % of the New Zealand population had
met criteria for a diagnosable mental disorder during their
life, and roughly a fifth had experienced a mental disorder
in the previous year [4].
In New Zealand, as in other OECD countries, mental
health problems are very common in primary care and
general practice. It is estimated in New Zealand that
50–70 % of mental health concerns are managed exclu-
sively at the primary care level [5]. Primary mental
health care is thus appropriately concerned with the
promotion of mental health, and the prevention, assess-
ment, early intervention, treatment and ongoing manage-
ment of mental health concerns [5].
Primary care services in New Zealand are expected to
respond to more of the mental health needs of the
population, as secondary services become more tar-
geted towards severe and enduring mental illness.
However, treatment options for mental health problems
at the primary care level are limited [5]. Between
26.5 % and 29.8 % (men and women, respectively), of
primary care patients in New Zealand are thought to
have mild to moderate mental health concerns by their
GPs [6]. People with these problems can experience
significant impairment in functioning and suffering [7,
8], indicative that treatment is required [9]. Individuals
with ‘minor’ or mild to moderate depressive symptoms
can have similar levels of functional impairment and
place similar demands on mental and physical health
services as those with more recognized diagnoses, such
as major depression [10]. Some individuals with mild to
moderate mental health issues will go on to develop se-
vere depression [11, 12].
Unsurprisingly, there is a large unmet need for treat-
ment options for common mental health concerns in
primary care services in New Zealand [5, 13]. Although
GPs identified that 90 % of patients who received an ex-
plicit diagnosis received treatment for mental health
needs, as few as 22 % of people with mild to moderate
mental health symptoms received any form of formal
help [14].
It is important that primary care provides services to
those who are disadvantaged in terms of access to mental
health care. This includes those at socioeconomic dis-
advantage and many of those from Māori (the indigenous
people of New Zealand) and Pacific Island populations [4].
Rates of common mental disorders in general practicesettings are higher for Māori than non-Māori, although
Māori are less likely than non-Māori to have been identi-
fied by their GP as having mild to moderate symptoms
(15.3 % versus 23.2 %) [15].
Primary care practitioners need a range of interven-
tions to call on, and evidence is emerging for ‘ultra-brief ’
and self-help interventions, such as bibliotherapy, for
mild to moderate syndromes [16–18]. It is critical that
interventions are developed that are suitable for delivery
by clinicians in primary care settings without the need
for referral to other professionals, such as counsellors.
This aids accessibility in that many people may feel more
comfortable discussing concerns with a trusted GP than
with a ‘counsellor’. Furthermore, referral to external ser-
vices may not be possible, owing to waiting lists, criteria
for service entry, or due to a lack of funds. It is also im-
portant that such interventions can be accommodated
within the usual time frames of general practice consulta-
tions. A standard individual consultation in many OECD
countries would last between 10 and 15 minutes, though
consultation for any mental health problem might be
spread over three or four visits.
In keeping with this unmet need for treatment, we de-
veloped and feasibility-tested an ultra-brief intervention
(UBI) for mild to moderate mental health problems in
New Zealand primary care [19]. The UBI uses a guided
self-help format, involving three brief, structured face-
to-face sessions with a GP, supported by self-help book-
lets across four topics: stress management, relationships,
harmful behaviors, and bodily stress. These topics were
selected because 36 % of general practice attendees re-
port anxiety, depression or substance use, or a combin-
ation of these issues [6]. In addition, symptoms of bodily
stress (previously referred to as medically unexplained
symptoms) are common presentations in primary care
settings [20, 21], and are being considered as a new diag-
nosis (ICD-11-PHC) in the forthcoming International
Classification of Diseases [22]. This was reflected in GP
feedback that indicated a need for resources on bodily
stress. The face-to-face intervention and booklets were
adapted for Māori providers and patients, and were
found to be relevant and acceptable to both clinicians
and their Māori patients [23, 24].
The UBI fits with a stepped care approach to mental
health care in New Zealand, in which interventions
range from self-help to professional help-seeking, de-
pending on symptom severity and response to treatment.
The UBI requires minimal training, no specialist coun-
selling knowledge and incorporates techniques already
familiar to most primary care clinicians. It requires only
one hour of face-to-face time with the patient in total.
Furthermore, it can feasibly be delivered in primary care
without referral to another professional, therefore im-
proving accessibility and acceptability of treatment for
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of acceptability among primary care clinicians and patients
were found, and the UBI yielded significant clinical im-
provements at 3 month follow-up, for both non-Māori
[19] and Māori [23].
Despite evidence for the individual elements within
the UBI, there has been no randomized controlled trial
of the effectiveness of such a therapy delivered routinely
in primary care. Thus, the aim of this trial is to investi-
gate the clinical effectiveness of UBI for individuals who
present with mild to moderate mental health needs in
primary care settings compared with practice as usual,
in a randomized controlled trial in a real-world study
design. Specifically, we have the following objectives:
1. To compare mental health state (as measured by
K10 scores) at 26 weeks between the UBI and
practice-as-usual study arms. This is the primary
outcome measure.
2. To compare levels of distress (depression and
anxiety) and functioning (work, social and
relationship) at 8 and 12 weeks between the UBI and
practice-as-usual study arms. These are the secondary
outcome measures.
Methods/Design
We are using a pragmatic two-arm single-blinded,
cluster randomized controlled trial of the UBI for mild
to moderate mental health concerns compared with
practice as usual, in a primary care setting. General
practitioners have been randomized by practice to exclu-
sively deliver either the UBI or practice as usual to all their
recruited participants. The GPs are treated as the clusters
in the study design (while there will be clustering by GP
practice, the GPs are being treated as the unit of analysis,
as practitioner attribute is anticipated to be a higher
source of variability in outcomes.)
Setting
The study is being conducted in general practices in the
greater Wellington region, New Zealand.
Participants
This is a real-world trial supported in the framework of
existing treatment services. Patients aged between 18
and 65 who are identified by their GPs in a routine ap-
pointment as experiencing distress and needing a mental
health intervention are eligible to participate. All partici-
pants must also score 35 or less on the Kessler 10 (K10)
assessment scale, which measures global psychological
distress, during their initial GP consultation. These
scores were selected to indicate mild to moderate levels
of psychological distress. There is no lower cut off score,
since initial inclusion is based on the GP identifying aclinical problem that would be managed at the GP level.
Previous work in New Zealand general practice using
the K10 has demonstrated that clinicians do not select
patients with very low K10 scores (<20) for clinical inter-
vention [5]. The K10 demonstrated sensitivity and speci-
ficity for anxiety and depressive disorders, where scores
exceeding 30 indicate a ‘very high’ risk of having a men-
tal disorder [25]. This study follows previous study pro-
tocols [19, 23], where scores falling between 30 and 35
on the K10 were indicative of mild to moderate levels
of psychological distress rather than a diagnosis of
major psychiatric disorder, and were therefore included.
Individuals receiving treatment with anti-depressant or
other psychiatric medications are eligible to participate
in the study.
Exclusion criteria for patients are non-fluency in
English (as the intervention is an English-language
based ‘talking therapy’), significant levels of cognitive
impairment, as determined by the GP, and recent or
acute suicidal ideation (i.e., within the previous
2 weeks). Chronic low level suicidality being managed
by the GP does not exclude an individual from partici-
pating, except for those individuals who have high
current levels of distress, indicated by K10 scores ex-
ceeding 35 at baseline. General practitioners are in-
formed of patients who have high scores or suicidality
at screening, or for whom referral to appropriate sec-
ondary mental health services is indicated, and these
patients would not be eligible to participate further in
the study. Participants are still eligible to participate if
their K10 scores increase above 35 during the study,
and if, in the active intervention group, they have also
completed two out of three sessions of the UBI.
Inclusion criteria are based on the access criteria of a
local partner primary health organization to psychological
therapies. The criteria for access are specifically targeted
at youth (defined as 18 to 24 years old), and, for indi-
viduals aged 25 years or older, patients with low in-
come, or Māori or Pacific Island heritage. In line with
the focus on access for youth to mental health interven-
tions, two youth-specific services were also included in the
study. The GP practices were eligible for inclusion in the
study if they were members of the local partner primary
health organization: no further inclusion or exclusion
criteria were applied at the practice level.
Recruitment methodology and randomization
Initial recruitment of GP practices was with the support
of the partner primary health organization. The GPs
were identified using primary health organization and
practice lists. All of the GP practices contracted under
the partner primary health organization were contacted
(N = 52) and invited to participate in the study, and an
effort was made to contact all of the GPs within these
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practices consented to participate in the study. To safe-
guard against gross imbalances in number of GPs per
study arm, a cluster randomization schedule was created,
with randomization restricted by the numbers of GPs in
each practice (two medium-size practices were com-
bined in one stratum to balance one very large practice).
Of the 63 GPs who originally consented to participate,
59 completed a single two-hour training session (previ-
ously described [19]) and returned a signed consent
form. Practices agreeing to take part were randomly
assigned to provide either the brief intervention or prac-
tice as usual to eligible patients attending their surgeries.
To ensure approximately equal numbers of GPs per study
arm, randomization of practices was conducted within five
blocks, according to the number of participating GPs: one,
two, three, four, or more than four GPs. An additional two
practices dedicated to youth health that are not part of the
partner primary health organization were included and
randomized into each arm of the study (i.e., these two
practices formed their own stratum). Practices assigned to
the practice-as-usual study arm will receive training in the
intervention at the end of the study.
Recruitment procedures
During routine clinical practice, GPs identify people with
common mental health problems, who might fulfil study
criteria. The diagnosis of common mental health prob-
lems is made by the GP. These patients are screened for
eligibility (using the K10), and referred to the study. A
research assistant then recruits participants by con-
ducting the informed consent procedures and collects
pre-treatment (baseline) data. Measures are then col-
lected by mail or email after treatment (8, 12, and
26 weeks). Participants receive compensation (NZ $30
US $21 vouchers, a draw for an iPad) following com-
pletion of the final questionnaire, to recompense for time
and effort in participating in the study.
Intervention
The UBI is a structured and guided self-management
program, and can be delivered by a GP after a single
two-hour training session. Participants who have con-
sented and completed the intake data collection (K10
and baseline measurements) will receive the GP-led
intervention in three short, structured face-to-face ses-
sions (one 30 minute and two 15 minute sessions) over a
five to six week period. The UBI is a self-help approach
based on structured problem solving and cognitive be-
havior therapy and is supported by self-help booklets
on relationships, bodily stress, breaking habits and
stress management. Booklets are provided to the pa-
tient after the first session, to be used in the following
session. The intervention resources have been adaptedto better meet the needs of Māori participants, and in-
clude Māori imagery, Te Reo (language), wairua (spir-
ituality), whanau (family) and whakatauki (proverbs),
the face-to-face sessions can include whakawhanaun-
gatanga (the process of forming connections), and offer
karakia (prayer) at the start. Measures will be collected
by the research assistant before (baseline) and after
treatment (8, 12, and 26 weeks). Participants can revert
to practice as usual following the completion of the
brief intervention. Participants can commence mental
health medications at any time, or withdraw from the
study and change to another intervention pathway dur-
ing UBI, if deemed clinically necessary by their GP or
other healthcare providers. Participants are considered
to have completed the intervention if they attended at
least two out of the three sessions with their GP. Increas-
ing K10 scores during the study are not a reason for with-
drawal for either intervention or control group.
Practice as usual
Participants in the practice-as-usual study arm will receive
GP support delivered according to their practice (and avail-
able existing services) as usual. Practice as usual typically
consists of supportive counselling in a 15 minute face-to-
face consultation, the provision of psychotropic medica-
tion, referral to psychological or other counselling options,
or referral to relevant community services. All measures
will be collected according to the same timescale and
methodology as the intervention arm. The UBI is excluded
as a component of practice-as-usual arm.
Outcome measures
The primary outcome measure is the Kessler Psychological
Distress Scale (K10) [26, 27] score at 26 weeks (adjusted
for score at baseline: see analysis). The K10 is widely used
as a clinical outcome measure in primary care and general
practice [5]. Higher K10 scores indicate a greater likelihood
of meeting criteria for a mental disorder diagnosis [27],
meaning reductions in K10 scores post-treatment will
represent real change in mental health status.
Secondary outcome measures are:
1. Hospital Anxiety and Depression Scale (HADS) [28].
This measures severity of depressive and anxious
symptoms in outpatient hospital settings [28].
Reductions in HADS score will indicate reduced
anxiety and depression. Given the nature of
‘sub-threshold’ common mental disorder, the HADS
score will use the combined anxiety and depression
subscales. Patients in the study are likely to have
lower scores than those that might be used for
categorical case definition; hence, scores have been
used as continuous variables.
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8 weeks and 12 weeks, adjusted for baseline scores
(to capture short- and medium-term effectiveness).
3. Work and Social Adjustment Scale [29]: a measure
of work, social and relationship functioning) at
baseline, 8, 12, and 26 weeks.
4. Sociodemographic data will include the NZDep2006
[30], a New Zealand index of individual
socioeconomic deprivation.
All clinicians will be asked to complete measures of
satisfaction with the intervention at the end of the study,
and a randomly selected group of 20 patients will be
asked to complete measures of satisfaction with the
intervention at 6 weeks post-intervention. These data
will be used to inform further operational development
of the tool, should the result of the trial affirm its value
to clinical practice.
Statistical methods
Sample size and power analysis
Sample size was calculated using a simulation approach,
based on standard deviations from a sample of similarly
eligible patients from the UBI development study (stand-
ard deviation of post-treatment scores = 7.5; unpublished
data). For 80 % power to detect a difference in K10 im-
provement scores of 6 points in the UBI arm, compared
with 2 points in the control arm, would require 15 GPs
per arm, each recruiting eight completing patients on
average (n = 240 total with complete data). Adjusting for
loss to follow-up of 20 % gives a recruitment target of
ten patients per GP. The simulation settings roughly
correspond to an intraclass correlation of 0.15 for con-
sidering the clustering of patient scores due to GPs:
this corresponds to the intraclass correlation from the
unpublished data from the development study. A power
analysis for the secondary HADS scale outcome indi-
cated that the study would have 80 % power to detect a
difference of 3.2 points between groups (based on a
standard deviation for the total score of approximately
6 for a general practice sample [31], with the same
sampling design, and assuming a similar intraclass
correlation for the HADS scale as used for the K10
measure (empirical data not available)).
Analysis
The statistician performing data analysis will be blinded
to the intervention or control status of participants
(both practices and patients). For the primary outcome,
K10 scores at 26 weeks will be compared between the
intervention and control groups using a mixed linear
models application of analysis of covariance (comparing
post-intervention scores between groups, adjusting for
intake score as a covariate, and treating GP clusters asrandom effects). Data analysis will be conducted on an
intention-to-treat basis. Missing data for the 26-week
follow-ups will be handled through the mixed linear
models approach to the data, which allows for partici-
pants with missing data for the final follow-up to be in-
cluded in analyses (this in effect estimates a final
outcome value conditional on the observed data at other
follow-up times.) This missing data method is valid
under the assumption that the missing observations are
missing at random, conditional on the observed data
[32, 33]. The null hypothesis for this test is that the K10
scores at 26 weeks (adjusted for baseline score) are not
different in the intervention and control groups.
To account for stratification by type of practice (youth-
health focused practices, in contrast to unrestricted GP
practices) we will conduct a sensitivity analysis looking at
data just from the unrestricted GP practices (i.e. excluding
the two practices in the youth-health stratum).
For the secondary analysis, differences in mean scores
on the K10 outcome will also be reported at 8 and
12 weeks (using the same methods as before, within the
mixed linear models framework). Analysis of the HADS
combined score will utilize the same methods as for the
K10 outcome.
The findings of this study will be reported in line
with the CONSORT statement, as adapted for cluster
randomized trials [34].
Confidentiality and data management
Consenting participants are explained their rights and
provision for data confidentiality. Paper and digital cop-
ies of the data are secured in locked storage on the
premises of the University of Otago, Wellington. The
questionnaire data will be de-identified and entered into
a spreadsheet for subsequent analysis.
Ethics issues
Adverse events are not anticipated in this trial, and ar-
rangements have been made to feedback clinical informa-
tion to primary care GPs if deemed necessary (e.g., high
K10 scores, or concerning self-reported statements about
a participant’s safety, in the course of data collection).
Ethical approval
Ethical approval was received from the Health and Dis-
ability Ethics Committee of the Ministry of Health
(Northern B Health and Disability ethics committee
12/NTB/2).
Discussion
The study, due to report its findings in 2016, tests the
clinical effectiveness of a UBI for common mental health
concerns in primary care. The objective of this trial is to
determine whether a brief psychological treatment (the
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in New Zealand is effective in reducing the disability and
distress associated with mild to moderate mental health
problems, by improving functioning, symptoms and
quality of life, compared with practice as usual.
One potential strength of UBI for clinical practice is that
an empirically derived brief structured psychological inter-
vention for primary care could reduce the distress and dis-
ability associated with mild syndromes. A randomized
controlled trial will also strengthen the evidence base for
the appropriate clinical management of mild to moderate
mental health conditions in primary care. The UBI might
be more cost-effective in improving clinical outcomes than
current practice, as it can be delivered in primary care set-
tings without referral to another professional, by clinicians
without specialist training, and using inexpensive mate-
rials. The UBI might also reduce the financial burden of
seeking expensive, external, and over-subscribed services
outside of primary care settings. It empowers individual
practitioners to address psychological concerns in primary
care settings without the reliance on mental health medi-
cations, which might not be otherwise indicated. The UBI
is also a culturally sensitive intervention, tailored to the in-
digenous Māori peoples of New Zealand [23].
If the effectiveness of the intervention is supported by
this trial, it will make a significant difference to clinical
practice and patient outcomes in New Zealand. The UBI
will contribute to workforce development, by up-skilling
GPs to deliver the intervention. No specialist psycho-
therapy knowledge is needed to deliver the UBI, minimal
training is required for GPs, and, furthermore, the UBI
incorporates techniques already familiar to many primary
care clinicians.
The UBI further benefits the community, as it is a
first-line intervention tool for addressing commonly oc-
curring mental health concerns in primary care settings.
The UBI is consistent with the contemporary primary
care stepped care approach that tailors interventions to
symptom severity and response to treatment. It might
also improve access to treatment for patients who would
not otherwise seek external support. Feasibility studies
have identified that the UBI leads to substantive short
term improvement in mental health [19]. Furthermore,
the findings of the intervention are known to be accept-
able to, and were suggestive of clinical efficacy for, Māori
patients. Patients with Māori heritage reported a high
level of satisfaction after completing the sessions, and
with the adapted imagery and Te Reo Māori included in
the booklets [23]. This work has the potential to contrib-
ute to more equitable outcomes for Māori with mild to
moderate mental health needs, and to empower GPs to
work in a bi-culturally safe and skillful way.
A potential limitation is that the study is only open to
patients who meet the funding criteria for the partnerprimary health organization. In real terms, participants
aged 25 or older can only participate in the study if they
hold a community services card or are of Māori or Pa-
cific heritage. Applications for additional funding are
underway, to increase access into the study for the general
population. A result of the restricted eligibility criteria is a
necessary extension of the study timeframe, which might
impact the rate of recruitment and attrition of GPs partici-
pating in the trial. Despite the challenges inherent in any
full-scale trial, our vision is that the UBI will form part of
the standard skillset for all primary care clinicians in New
Zealand.
Trial status
Recruitment to the Stress in Primary Care (UBI) study
commenced in May 2013. Participants are expected to
complete all follow-up measures in late 2015.
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